Importantly, the presence of such IDO-specific CD8+ T cells boosted T-cell immunity against viral or tumor-associated antigens by eliminating IDO+ suppressive cells thereby directly targeting the IDO-dependent counter-regulatory pathway [16]. This evidence concerns the gene CD8A and neoplasm.